48,453
edits
(3 intermediate revisions by the same user not shown) | |||
Line 6: | Line 6: | ||
| Micro = | | Micro = | ||
| Subtypes = many see ''[[squamous cell carcinoma]]'' | | Subtypes = many see ''[[squamous cell carcinoma]]'' | ||
| LMDDx = [[inverted follicular keratosis]], [[Paget disease of the breast]], [[eccrine carcinoma]], [[atypical fibroxanthoma]], [[malignant melanoma]], [[leiomyosarcoma]], [[basal cell carcinoma]] (for ''[[basaloid squamous cell carcinoma]]'') | | LMDDx = [[inverted follicular keratosis]], [[Paget disease of the breast]], [[eccrine carcinoma]], [[atypical fibroxanthoma]], [[malignant melanoma]], [[leiomyosarcoma]], [[basal cell carcinoma]] (for ''[[basaloid squamous cell carcinoma]]''), [[porocarcinoma]], [[pseudoepitheliomatous hyperplasia]] | ||
| Stains = | | Stains = | ||
| IHC = CK5/6 +ve, p63 +ve, K903 +ve, [[Ber-EP4]] -ve, S-100 -ve | | IHC = CK5/6 +ve, p63 +ve, K903 +ve, [[Ber-EP4]] -ve, S-100 -ve | ||
Line 80: | Line 80: | ||
*[[Eccrine carcinoma]]. | *[[Eccrine carcinoma]]. | ||
*[[Basal cell carcinoma]] for [[basaloid squamous cell carcinoma]]. | *[[Basal cell carcinoma]] for [[basaloid squamous cell carcinoma]]. | ||
*[[Porocarcinoma]]. | |||
*[[Pseudoepitheliomatous hyperplasia]]. | |||
===Grading=== | ===Grading=== | ||
Line 136: | Line 138: | ||
|- | |- | ||
| T2 | | T2 | ||
| >2 cm and less than two high-risk factors ''or'' two | | >2 cm and less than two high-risk factors ''or'' two or more high-risk factors | ||
| see ''microscopic'' for list of high-risk factors | | see ''microscopic'' for list of high-risk factors | ||
|- | |- |
edits